---
$id: https://graph.org.ai/products/commodity/51162602
$type: Product
source: UNSPSC
code: "51162602"
title: "Bibenzonium"
class: "51162600"
classTitle: "Antitussives and associated cough remedies"
family: "51160000"
familyTitle: "Drugs affecting the respiratory tract"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Bibenzonium

**UNSPSC Code**: 51162602
**Class**: [Antitussives and associated cough remedies](Antitussives and associated cough remedies.mdx)
**Family**: [Drugs affecting the respiratory tract](../Drugs affecting the respiratory tract.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an antitussive agent with the molecular structure C19H26NO, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier, 34YTZ517S2 chemically known as (2-(1,2-diphenylethoxy)ethyltrimethyl)ammonium, but more commonly known as bibenzonium, which bears US NIH Compound Identifier 71954. European Medicines Agency schedules Bibenzonium in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB00798MIG. As of Q4 2014, BIBENZONIUM remains US FDA's Preferred Term for this commodity. Bibenzonium bears US NLM identifiers UMLS ID C2347006 and NCI Concept Code C73821. SMILES: O(CC[N](C)(C)C)C(CC1CCCCC1)C1CCCCC1.

